Jan G.
- Country
- Poland
- Department
- private clinic
Research Overview
- Long-term Safety and Tolerability of Linerixibat in Cholestatic Pruritus Associated with Primary Biliary Cholangitis
- ADVANCE: A Phase III Multi-Centre, Randomised, Double-Blind, Double-Dummy Clinical Trial Comparing Essentiale® Liquid vs. Capsules for MASLD/MASH, Alcoholic Liver Disease, and Chronic Viral Hepatitis B
Data & Insights
Has run more than one trial at 2 of 56 partner sites.
Specializations
Hepatic Disorders
The investigator specializes in treating patients with Primary Biliary Cholangitis (PBC), focusing particularly on managing associated symptoms and complications.
- Cholestatic conditions
- Liver disease management
- Biliary disorders
Clinical interest extends to therapeutic approaches for cholestatic pruritus and other manifestations of chronic liver conditions.
Clinical Therapeutics
Dedicated to advancing treatment options for patients with chronic cholestatic liver diseases, with particular attention to innovative therapeutic agents.
- Novel therapeutic approaches
- Long-term treatment strategies
- Patient safety monitoring
Focuses on evaluating therapeutic interventions for chronic liver conditions requiring extended treatment periods.
Symptom Management
Expert in addressing quality-of-life impacting symptoms associated with chronic liver diseases, particularly focusing on pruritus management.
- Pruritus control
- Symptom assessment
- Treatment tolerability
Specializes in developing comprehensive approaches to managing challenging symptoms in hepatic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.